NCT01436877View on ClinicalTrials.gov

Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Bladder Neck ObstructionBenign Prostate Hyperplasia
Interventions
DEVICE

Insertion of Temporary Implantable Nitinol Device (TIND)

Subjects will be inserted with the Temporary Implantable Nitinol Device (TIND) to the bladder neck and urethral prostate for 5 days and thereafter the TIND will be withdrawn in the doctor office.

Trial Locations (1)

Unknown

Meir Medical center, Kfar Saba

Sponsors

Lead Sponsor

Medi-Tate Ltd.
All Listed Sponsors
lead

Medi-Tate Ltd.

INDUSTRY

NCT01436877 - Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia | Biotech Hunter | Biotech Hunter